Biomarkers for Locally Advanced Hepatocellular Carcinoma Patients Treated with Liver-Directed Combined Radiotherapy
Introduction: In the era of biomarker-driven cancer therapy, robust biomarkers for hepatocellular carcinoma (HCC) have not been well-defined. In this hypothesis-generating study, we investigated biomarkers that can be incorporated to predict treatment outcomes in patients with locally advanced HCC w...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
S. Karger AG
2022
|
| Subjects: | |
| Online Access: | View Fulltext in Publisher |